Previous studies have shown that DNMT3A is among the most frequently mutated genes in AML, MPN, MDS, and adult-early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) [16, 22–26]. This evidence concerns the gene DNMT3A and myeloproliferative disorder.